Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FBXW7 |
Variant | D527G |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | FBXW7 D527G lies within WD repeat 4 of the Fbxw7 protein (UniProt.org). D527G retains the ability to target Myc, Mcl-1, Braf, and Cyclin E for degradation (PMID: 32907612 , PMID: 27247421), binds to the large T antigen of Merkel cell polyomavirus similar to wild-type Fbxw7, and demonstrates increased binding to small T antigen in culture (PMID: 32427880), but results in decreased binding to Mlst8 (PMID: 34741373), fails to bind and degrade NICD in cultured cells leading to increased Notch transcriptional activity in a reporter assay, and results in transformation in the context of the viral protein, Tax, in culture (PMID: 27247421), and therefore, is predicted to lead to a loss of Fbxw7 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
FBXW7 mutant FBXW7 inact mut FBXW7 D527G |
Transcript | NM_033632.3 |
gDNA | chr4:g.152326070T>C |
cDNA | c.1580A>G |
Protein | p.D527G |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011532084.2 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
NM_033632.3 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_011532085.2 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_024454123.1 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_047415899.1 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_024454122.1 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_011532084.3 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
NM_033632.3 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_047415900.1 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
NM_001349798.2 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_024454121.1 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_024454123.2 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_047415898.1 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_011532085.3 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
NM_001349798.1 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_047415901.1 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_047415897.1 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
XM_024454124.1 | chr4:g.152326070T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
NM_018315.5 | chr4:g.152324219T>C | c.1580A>G | p.D527G | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|